Hospira Recalls One Lot of Sodium Chloride Injection Due to Particulate Matter

Article

Hospira, Inc, of Lake Forest, IL, has announced a voluntary nationwide recall of one lot of 0.9% Sodium Chloride Injection, USP, 250 mL (NDC 0409-7983-02, expiration August 1) due to the presence of particulate matter.

Hospira, Inc, of Lake Forest, IL, has announced a voluntary nationwide recall of one lot of 0.9% Sodium Chloride Injection, USP, 250 mL (NDC 0409-7983-02, expiration August 1) due to the presence of particulate matter. Hospira identified the particulate matter as a human hair, sealed in the bag at the additive port area. To date, Hospira has received no reports of adverse events associated with the recall, according to a

Safety Alert

posted to the FDA website. The affected lot, 44-002-JT, was distributed nationwide from September 2014 through November 2014. Hospira advises health care providers to stop use and distribution of the product and quarantine it immediately. The company has notified its direct distributors via a recall letter and is arranging for impacted product to be returned. Adverse reactions may be reported to FDA’s

MedWatch

Safety Information and Adverse Event Reporting Program.

Related Videos
BillionPhotos.com - stock.adobe.com
Whole psilocybin mushroom in a clear medication capsule | Image credit: Zim - stock.adobe.com
Patient suffering from atopic dermatitis -- Image credit: Nikkikii | stock.adobe.com
Image credit: Fabio Balbi | stock.adobe.com
Image credit: Melita - stock.adobe.com
Atopic dermatitis on a patient's hand -- Image credit: Ольга Тернавская | stock.adobe.com
cropped view of man performing chest compression on dummy during cpr training class - Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Medicine law concept. Judges gavel with pills | Image Credit: Iren Moroz - stock.adobe.com
Image credit: New Africa | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.